HOXA9 and chronic myelogenous leukemia, BCR-ABL1 positive: This study is an initial step to define the proportion of HOXA9 gene expression in some Egyptians with chronic-phase CML at diagnosis and to evaluate its relation with BCR-ABL expression and its clinical significance.